News Release

Printer Friendly Version View printer-friendly version
<< Back
Amgen Raises EPOGEN Pricing
Contact: LeAnne Zumwalt
Investor Relations
Total Renal Care, Inc.
310-792-2600 ext. 2072

TORRANCE, Calif., April 29 DaVita Inc. announced that it has received notice that Amgen Inc. has increased the Wholesaler Acquisition Price for EPOGEN by 3.9%, effective April 25, 2002 at 5:01 PM Pacific Time. This pricing increase will affect DaVita beginning January 1, 2003.

DaVita is a leading provider of dialysis services for patients suffering from chronic kidney failure. The Company owns and operates kidney dialysis centers and home peritoneal dialysis programs domestically in 32 states, as well as Washington, D.C. As of December 31, 2001, we operated 493 outpatient dialysis facilities serving over 42,000 patients, including 3,300 patients in 32 centers under management. We also provide acute hemodialysis services to inpatients at approximately 280 hospitals.

This site is for informational purposes only and is not intended to be a substitute for medical advice from a physician. Please check with a physician if you need a diagnosis and/or for treatments as well as information regarding your specific condition.